Both of these kinases are increased as a consequence of the inflammatory program in obesity (Reilly et al., 2013), and contain NFκB regulatory sites in their promoter regions, allowing them to be induced upon NFκB activation (Kravchenko et al., 2003). The gene discussed is NFKB1; the disease is obesity due to melanocortin 4 receptor deficiency.